The evolution of thymic lymphomas in p53 knockout mice

Genes and Development

Volumn 28, Issue 23, 2014, Pages 2613-2620

  Dudgeon, Crissy ^a   Chan, Chang ^a,b   Kang, Wenfeng ^a   Sun, Yvonne ^a   Emerson, Ryan ^c   Robins, Harlan ^c,d   Levine, Arnold J ^a,e  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Adaptive Biotechnologies   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Chromosome abnormalities; Clonality; Mutation rate; p53; Pten; T cell lymphoma

Indexed keywords

MUS;

CDK6 PROTEIN, MOUSE; CYCLIN D; CYCLIN DEPENDENT KINASE 6; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PTEN PROTEIN, MOUSE;

ANIMAL; COPY NUMBER VARIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LYMPHOMA; MALE; MOLECULAR EVOLUTION; POINT MUTATION; THYMOMA;

ANIMALS; CYCLIN D; CYCLIN-DEPENDENT KINASE 6; DNA COPY NUMBER VARIATIONS; EVOLUTION, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOMA; MALE; MICE, KNOCKOUT; POINT MUTATION; PTEN PHOSPHOHYDROLASE; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84914132455     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.252148.114     Document Type: Article

References (28)

1. Carlson CS, Emerson RO, Sherwood AM, Desmarais C, Chung MW, Parsons JM, Steen MS, LaMadrid-Herrmannsfeldt MA, Williamson DW, Livingston RJ, et al. 2013. Using synthetic templates to design an unbiased multiplex PCR assay. Nat Commun 4: 2680.
2. Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C, Benedetti A, Vinante F, Pizzolo G, Inghirami G. 1998. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/ leukemia. Am J Pathol 152: 209-217.
3. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. 2013. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31: 213- 219.
4. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, Park SH, Thompson T, Ford RJ, Bradley A. 1995. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14: 16-22.
5. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, et al. 2002. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1: 75-87.
6. Gopalakrishnan S, Majumder K, Predeus A, Huang Y, Koues OI, Verma-Gaur J, Loguercio S, Su AI, Feeney AJ, Artyomov MN, et al. 2013. Unifying model for molecular determinants of the preselection Vb repertoire. Proc Natl Acad Sci 110: E3206-E3215.
7. Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, et al. 2009. High frequency of PTEN, PI3K, and AKTabnormalities in T-cell acute lymphoblastic leukemia. Blood 114: 647-650.
8. Hatta Y, Koeffler HP. 2002. Role of tumor suppressor genes in the development of adult Tcell leukemia/lymphoma (ATLL). Leukemia 16: 1069-1085.
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253: 49-53.
10. Kathrein KL, Chari S, Winandy S. 2008. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation. J Biol Chem 283: 10476- 10484.
11. Kleinmann E, Geimer Le Lay AS, Sellars M, Kastner P, Chan S. 2008. Ikaros represses the transcriptional response to Notch signaling in T-cell development. Mol Cell Biol 28: 7465-7475.
12. Lane DP. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16.
13. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499: 214- 218.
14. Levine AJ, Oren M. 2009. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9: 749-758.
15. Levine AJ, Momand J, Finlay CA. 1991. The p53 tumour suppressor gene. Nature 351: 453-456.
16. Li X, Gounari F, Protopopov A, Khazaie K, von Boehmer H. 2008. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med 205: 2851-2861.
17. Malkin D. 2011. Li-Fraumeni syndrome. Genes Cancer 2: 475- 484.
18. Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna I, et al. 2007. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 447: 966-971.
19. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. 2010. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
20. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, et al. 2008. BCRABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453: 110-114.
21. Newton RH, Turka LA. 2012. Regulation of T cell homeostasis and responses by pten. Front Immunol 3: 151.
22. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572.
23. O'Neil J, Calvo J, McKenna K, Krishnamoorthy V, Aster JC, Bassing CH, Alt FW, Kelliher M, Look AT. 2006. Activating Notch1 mutations in mouse models of T-ALL. Blood 107: 781-785.
24. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS. 2009. Comprehensive assessment of T-cell receptor b-chain diversity in ab T cells. Blood 114: 4099-4107.
25. Sathirapongsasuti JF, Lee H, Horst BA, Brunner G, Cochran AJ, Binder S, Quackenbush J, Nelson SF. 2011. Exome sequencing- based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics 27: 2648-2654.
26. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, et al. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4: 451-461.
27. Sun L, Crotty ML, Sensel M, Sather H, Navara C, Nachman J, Steinherz PG, Gaynon PS, Seibel N, Mao C, et al. 1999. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5: 2112- 2120.
28. Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.